| Literature DB >> 12432832 |
Timothy M Lynch1, David H Gutmann.
Abstract
Neurofibromatosis 1 is one of the most common genetic conditions affecting the nervous system. Individuals with NF1 are predisposed to the development of peripheral nerve sheath tumors (neurofibromas and MPNSTs), astrocytomas (optic pathway gliomas), learning disabilities, seizures, strokes, macrocephaly, and vascular abnormalities. The NF1 tumor suppressor gene encodes a large protein (neurofibromin) that functions primarily as a RAS negative regulator, suggesting that targeted therapy for NF1 might derive from inhibition of the RAS signaling pathway.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12432832 DOI: 10.1016/s0733-8619(01)00019-6
Source DB: PubMed Journal: Neurol Clin ISSN: 0733-8619 Impact factor: 3.806